The week in health tech, explained in plain English.Get the free newsletter →
November 18, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Why One Pediatrician Calls Paid Paternity Leave Preventive Care

Paid paternity leave is medicine, not just a benefit. That is the argument pediatrician Nishant Pandya makes in a STAT News opinion piece, reframing time off for new fathers as a form of pediatric preventive care.

Pandya points to a growing body of evidence that fathers make unique, independent contributions to their children's health and development. When fathers are present in the early weeks, the argument goes, outcomes improve in ways that clinical visits alone cannot deliver. That positions leave policy alongside vaccines and well-child checks as a tool that shapes long-term health.

The framing matters because the United States remains an outlier among wealthy nations without guaranteed paid family leave, leaving employers and states to set their own rules. Casting leave as preventive care shifts the conversation from human resources to public health, giving clinicians, payers, and policymakers a clinical rationale to expand access. For the health industry, it is a reminder that some of the highest-value interventions happen outside the exam room.

Sources

More in Government

Government

US Loses Measles Elimination Status After a Year of Spread

Global health authorities say the US has lost its measles elimination status after the disease spread continuously for over a year, ending a 25-year milestone.

Why it matters: Losing measles elimination status signals that a highly contagious, vaccine-preventable disease is again circulating freely in the U.S., threatening public health gains.

Government

Mark Cuban's Cost Plus to Develop US-Made Ibogaine for HHS

Mark Cuban Cost Plus Drug Co. will lead HHS-backed research to develop a US-made ibogaine product for PTSD and other mental illnesses, supported by up to $4.9 million.

Why it matters: Federal funding for domestically made ibogaine signals rising government interest in psychedelics for hard-to-treat conditions like PTSD in veterans.